LogicBio Therapeutics
(NASDAQ) LOGC
LogicBio Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$26.00M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
LOGC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout LogicBio Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
Rishi Bajaj
Website
ir.contextlogicinc.comHeadquarters
San Francisco, CA 94104, US
LOGC Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-19%
Return on Capital
-147%
Return on Assets
-119%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$31.00M
EBITDA
$31.00M
Operating Cash Flow
$16.00K
Capital Expenditure
$0.00
Free Cash Flow
$16.00K
Cash & ST Invst.
$218.00K
Total Debt
$0.00
LogicBio Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
8
N/A
Net Income
$14.00M
-600.0%
EBITDA
$19.00M
-375.0%
Quarterly Fundamentals
Net Cash
$218.00K
-99.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-119.27%
N/A
Return on Invested Capital
-146.92%
N/A
Free Cash Flow
$10.00M
-400.1%
Operating Cash Flow
$10.00M
-400.1%